Lyka Labs - Quaterly Results

02 Nov 2023 Evaluate
The Revenue for the quarter ended  September 2023 of Rs. 267.60 millions grew by 20.94 % from Rs. 221.27 millions.The Net Loss for the quarter ended September 2023 is Rs. -2.92 millions as compared to Net Loss of Rs. -3.96 millions of corresponding quarter ended September 2022Operating Profit reported a sharp decline to 42.40 millions from 57.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 267.60 221.27 20.94 479.97 440.05 9.07 805.93 1643.49 -50.96
Other Income 3.04 10.39 -70.74 7.32 17.23 -57.52 34.52 27.20 26.91
PBIDT 42.40 57.70 -26.52 72.25 123.74 -41.61 190.52 1002.19 -80.99
Interest 11.71 29.14 -59.81 25.04 57.15 -56.19 115.70 199.21 -41.92
PBDT 30.24 27.19 11.22 46.76 65.21 -28.29 3.08 756.30 -99.59
Depreciation 34.63 34.55 0.23 67.98 68.69 -1.03 135.16 153.89 -12.17
PBT -4.39 -7.36 -40.35 -21.22 -3.48 509.77 -132.08 602.41 -121.93
TAX -1.47 -3.40 -56.76 -1.10 -2.79 -60.57 0.78 203.38 -99.62
Deferred Tax -2.47 -3.40 -27.35 -4.45 -2.79 59.50 -1.29 203.38 -100.63
PAT -2.92 -3.96 -26.26 -20.12 -0.69 2815.94 -132.86 399.03 -133.30
Equity 330.90 286.90 15.34 330.90 286.90 15.34 306.90 286.90 6.97
PBIDTM(%) 15.84 26.08 -39.24 15.05 28.12 -46.47 23.64 60.98 -61.23

Lyka Labs Share Price

143.35 2.55 (1.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.